Health, Medicine and Natural Healing 11

179,008 topics in this forum

1. RE: snip: ODAC minutes - single arm studies for AA

   By Guest guest, April 7, 2011
   • 0 replies
   • 20 views
   • 
   • Guest
   • April 7, 2011

2. OT: Talc Use Linked to Ovarian Cancer Risk - in Meeting Coverage, AACR

   By Guest guest, April 8, 2011
   • 0 replies
   • 30 views
   • 
   • Guest
   • April 8, 2011

3. RE: snip: ODAC minutes - first line low-toxic single agents for AA?

   By Guest guest, April 8, 2011
   • 0 replies
   • 19 views
   • 
   • Guest
   • April 8, 2011

4. UCSD Researcher Kipps Receives $750K Grant

   By Guest guest, April 25, 2011
   • 0 replies
   • 31 views
   • 
   • Guest
   • April 25, 2011

5. avoiding medical errors

   By Guest guest, April 25, 2011
   • 0 replies
   • 26 views
   • 
   • Guest
   • April 25, 2011

6. Expression analysis of genes located in the minimally deleted regions of 13q14 and 11q22-23 in chronic lymphocytic leukemia

   By Guest guest, April 23, 2011
   • 0 replies
   • 188 views
   • 
   • Guest
   • April 23, 2011

7. Insulin Potentiation Therapy?

   By Guest guest, April 23, 2011
   • 0 replies
   • 22 views
   • 
   • Guest
   • April 23, 2011

8. General health: is sugar beign or poison?

   By Guest guest, April 21, 2011
   • 0 replies
   • 31 views
   • 
   • Guest
   • April 21, 2011

9. Epigenetic Therapy

   By Guest guest, April 20, 2011
   • 0 replies
   • 33 views
   • 
   • Guest
   • April 20, 2011

10. rational combinations of targeted agents

    By Guest guest, April 18, 2011
    • 0 replies
    • 24 views
    • 
    • Guest
    • April 18, 2011

11. Treatment of Synchronous Mantle Cell Lymphoma and Small Lymphocytic Lymphoma with Bendamustine and Rituximab

    By Guest guest, April 16, 2011
    • 0 replies
    • 44 views
    • 
    • Guest
    • April 16, 2011

12. Dermatological complications following initiation of lenalidomide in a patient with chronic lymphocytic leukaemia

    By Guest guest, April 16, 2011
    • 0 replies
    • 26 views
    • 
    • Guest
    • April 16, 2011

13. Revlimid And Secondary Cancers: An Update

    By Guest guest, April 15, 2011
    • 0 replies
    • 22 views
    • 
    • Guest
    • April 15, 2011

14. PI3K inhibitors - a review

    By Guest guest, April 15, 2011
    • 2 replies
    • 27 views
    • 
    • Guest
    • April 16, 2011

15. Diverging trends in incidence and mortality, and improved survival of non-Hodgkin's lymphoma, in the Netherlands, 1989–2007

    By Guest guest, April 16, 2011
    • 0 replies
    • 34 views
    • 
    • Guest
    • April 16, 2011

16. Cytogenetic methods in chronic lymphocytic leukemia

    By Guest guest, April 16, 2011
    • 0 replies
    • 20 views
    • 
    • Guest
    • April 16, 2011

17. CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells

    By Guest guest, April 16, 2011
    • 0 replies
    • 35 views
    • 
    • Guest
    • April 16, 2011

18. CCR4 expression in a case of cutaneous Richter's transformation of chronic lymphocytic leukaemia (CLL) to diffuse large B cell lymphoma (DLBCL) and in CLL patients with no skin manifestations.

    By Guest guest, April 16, 2011
    • 0 replies
    • 40 views
    • 
    • Guest
    • April 16, 2011

19. Diet and exercise questions

    By Guest guest, April 20, 2011
    • 0 replies
    • 34 views
    • 
    • Guest
    • April 20, 2011

20. btk inhibitor: Encouraging account from a MCL survivor

    By Guest guest, April 21, 2011
    • 0 replies
    • 57 views
    • 
    • Guest
    • April 21, 2011

21. regarding drug shortages - a legislative proposal

    By Guest guest, April 22, 2011
    • 0 replies
    • 33 views
    • 
    • Guest
    • April 22, 2011

22. Noteworth interview: author of 'The Emperor of all Maladies'

    By Guest guest, April 22, 2011
    • 0 replies
    • 20 views
    • 
    • Guest
    • April 22, 2011

23. tips for sticky situations

    By Guest guest, April 23, 2011
    • 0 replies
    • 32 views
    • 
    • Guest
    • April 23, 2011

24. CLL With t(14;19)(q32;q13) Is Characterized by Atypical Morphologic and Immunophenotypic Features and Distinctive Genetic Features

    By Guest guest, April 23, 2011
    • 0 replies
    • 27 views
    • 
    • Guest
    • April 23, 2011

25. The Efficacy of HGAL and LMO2 in the Separation of Lymphomas Derived From Small B Cells in Nodal and Extranodal Sites, Including the Bone Marrow

    By Guest guest, April 23, 2011
    • 0 replies
    • 38 views
    • 
    • Guest
    • April 23, 2011